Biomaterial development for cardiopulmonary bypass

Perfusion

Volumn 16, Issue 5, 2001, Pages 381-390

  Gourlay, T ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; CD11B ANTIGEN; HEPARIN; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PLASTICIZER; POLYVINYLCHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BIOCOMPATIBILITY; CARDIOPULMONARY BYPASS; CELL SURFACE; CONTROLLED STUDY; EXTRACORPOREAL CIRCULATION; HOST RESISTANCE; HUMAN; INFLAMMATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RODENT;

EID: 0034830566     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765910101600508     Document Type: Article

References (31)

1. Immobilisation of macromolecules for obtaining biocompatible surfaces
2. Definition of biocompatibility
3. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children
4. Corticosteroids during operations using cardiopulmonary bypass
5. Effect of low-dose methyl prednisolone on serum cytokine levels following extracorporeal circulation
6. Effect of cardiopulmonary bypass and hemofiltration on plasma cytokines and protein leakage in pigs
7. A circuit to perform a combined ultrafiltration procedure in pediatric open-heart surgery
8. Modified ultrafiltration lowers adhesion molecule and cytokine levels after cardiopulmonary bypass without clinical relevance in adults
9. Techniques of applying a graphite-benzalkonium-heparin coating to various plastics and metals
10. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass
11. Heparin coated CPB circuits reduce circulating complement factors and IL6 in paediatric patients
12. A novel technique for cardiopulmonary bypass using vacuum system for venous drainage with pressure relief valve: An experimental study
13. Experimental use of an ultra-low prime neonatal cardiopulmonary bypass circuit utilising vacuum-assisted venous drainage
14. Influence of blood plasticised polyvinyl chloride: Significance of the plasticiser
15. Health risks posed by use of di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: A critical review
16. Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat
17. The potential health effects of phthalate esters in children's toys: A review and risk assessment
18. Exposure of hemodialysis patients to di-2-ethylhexyl pthalate
19. IV bags pose a patient risk
20. Does high-dose methylprednisolone in aprotinin-treated patients attenuate the systemic inflammatory response during coronary artery bypass grafting procedures?
21. Pump prime only aprotinin inhibits cardiopulmonary bypass-induced neutrophill CD11b up-regulation
22. Aprotinin: An update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery
23. Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface
24. Migration resistant, blood-compatible plasticized polyvinyl chloride for medical and related applications
25. Chemical studies on compatibility to medical application III. Prevention of migration of DEHP from blood tubings
26. The effect of polymer surface area on CD11b expression in a rat recirculation model
27. Evaluation of Carmeda bioactive surface (CBAS), Duraflo II and a novel non-specific protease-modified surface using a new in vitro model simulating cardiopulmonary bypass
28. Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules
29. Comparison between a new PVC platelet storage container (UPX80) and a polyolefin container
30. Properties of stored platelet concentrates: Effect of the suspension media and type of pouch used
31. Preprimed artificial lung for emergency use